StockData
Trinity Biotech PLC logo

Trinity Biotech PLC (TRIB) income statement

TRIBNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Apr 30, 2026Score 1/30
$5.83−0.18 (-3.08%)

Close on Nov 18, 2026Market cap $108.99MP/E –Yield –

Trinity Biotech PLC income statement

Ratios

Latest available, balances at Dec 31, 2025

Profitability, FY2025

Gross margin
38.6%
Operating margin
-36.1%
Net margin
-85.4%
Return on equity, FY2025
–

Financial strength

Current ratio
0.25
Debt to equity
–
Debt to assets
0.2%
Cash to current liabilities
3.6%

Valuation

P/E ratio
–
Price to sales
2.49
Price to book
–
Dividend yield
–

See a number that looks wrong?